https://www.selleckchem.com/pr....oducts/tenalisib-rp6
Background Anal cancer is a rare disease, which might be the reason for the "one size fits all" approach still used for radiotherapy target contouring. To refine and individualize future guidelines, detailed and contemporary pattern of recurrence studies are needed. Methods Consecutive anal cancer patients, all treated with curative intent intensity-modulated radiotherapy (IMRT), were retrospectively studied (n = 17. Data was extracted from medical records and radiological images. Radiotherapy planning CT's and treatment plan